therasphere

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1988-2017
02419882017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
BACKGROUND Hepatocellular carcinoma (HCC) is aggressive primary malignancy of the liver that most commonly presents late in the… (More)
Is this relevant?
2012
2012
Yittrium-90 microsphere brachytherapy procedures have increased in number due to their efficacy in treating some unresectable… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
Is this relevant?
2009
2009
We report a first experience involving the use of 90Y radiolabelled microspheres (TheraSphere) for the treatment of mainly… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
2009
Review
2009
Locoregional therapies, such as transarterial chemoembolization, radioembolization and thermal ablation (e.g., radiofrequency… (More)
Is this relevant?
2006
2006
Yttrium-90 ((90)Y) radioembolization is a catheter-based therapy that delivers internal radiation to hepatic tumors in the form… (More)
  • table 1
  • table 2
Is this relevant?
2005
2005
PURPOSE The purpose of this phase II study was to determine the safety and efficacy of TheraSphere treatment (90Y microspheres… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
PURPOSE Intraarterial injection of yttrium 90 microspheres (TheraSpheres) is used in the treatment of hepatocellular carcinoma… (More)
Is this relevant?
2005
2005
PURPOSE To present the findings of a risk-stratification survival analysis with use of data collected on a heterogeneous group of… (More)
Is this relevant?
2004
2004
This is a retrospective analysis of a new treatment modality, intra-arterial administration of Yttrium-90 TheraSphere, for… (More)
Is this relevant?
1988
1988
A 22-micron glass microsphere called TheraSphere (Theragenics Corp., Atlanta, GA) has been developed in which yttrium 89 oxide is… (More)
Is this relevant?